Recent Company News

• 04:35 AM ET Nov 10, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:55 AM ET Dec 01, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (72 total)

• 12:01 PM ET Nov 27, 2025
  

  GENFIT appoints Pejvack Motlagh as new Chief Medical Officer (€4.27, 0.00)

• 12:12 PM ET Nov 20, 2025
  

  GENFIT reports 9M revenue €39.2M, (34%) vs year-ago €59.7M (€3.72, 0.00)

• 12:01 PM ET Nov 20, 2025
  

  GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market (€3.72, 0.00)

• 01:47 AM ET Nov 10, 2025
  

  GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF (€3.42, 0.00)

• 01:32 AM ET Nov 10, 2025
  

  GENFIT presents promising new preclinical data on NTZ/G1090N in the treatment of ACLF at the Liver Meeting 2025 (€3.42, 0.00)

• 08:49 AM ET Nov 07, 2025
  

  Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO's long-term efficacy, safety and mechanistic insights in fatigue (€122.90, -0.20)

• 04:01 PM ET Oct 30, 2025
  

  GENFIT announces intention to voluntarily delist ADs from the Nasdaq (€3.64, 0.00)